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Abstract
Background: Streptococcus equi subsp. zooepidemicus is a beta-hemolytic group C streptococcus mainly causing
infections in domesticated animals. Here we describe the first case of zoonotic necrotizing myositis caused by this
bacterium.
Case presentation: The patient was a 73-year-old, previously healthy farmer with two asymptomatic Shetland
ponies in his stable. After close contact with the ponies while feeding them, he rapidly developed erythema of his
left thigh and sepsis with multiple organ failure. The clinical course was severe and complicated, requiring repetitive
surgical excision of necrotic muscle, treatment with vasopressors, mechanical ventilation and continuous venovenous
hemofiltration, along with adjunctive hyperbaric oxygen therapy. The patient was discharged from hospital at day 30,
without obvious sequelae.
The streptococcal isolate was identified as Streptococcus equi by MALDI-ToF MS, and was later assigned subspecies
identification as S. equi subsp. zooepidemicus. Multilocus sequence typing identified the strain as a novel sequence type
(ST 364), closely related to types previously identified in horses and cattle. A focused proteomic analysis revealed that
the ST 364 expressed putative virulence factors similar to that of Streptococcus pyogenes, including homologues of the
M protein, streptodornases, interleukin 8-protease and proteins involved in the biosynthesis of streptolysin S.
Conclusion: This case illustrates the zoonotic potential of S. equi subsp. zooepidemicus and the importance of early
clinical recognition, rapid and radical surgical therapy, appropriate antibiotics and adequate supportive measures when
necrotizing soft tissue infection is suspected. The expression of Streptococcus pyogenes-like putative virulence
determinants in ST 364 might partially explain the fulminant clinical picture.
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Background
Streptococcus equi subsp. zooepidemicus (S. zooepidemi-
cus) is a beta-haemolytic group C streptococcus able to
colonize the upper airways of horses and produce diverse
clinical manifestations in domesticated animals, including
respiratory tract infections, mastitis and meningitis [1–4].
S. zooepidemicus rarely causes human infection, and the
mechanism is supposed to be zoonotic transmission by
direct contact with infected or colonized animals or the
consumption of unpasteurized milk products [5–8]. This
streptococcus has been associated with a wide range of se-
vere human infections, including cellulitis, pericarditis,
toxic shock syndrome, endovascular infections, pneumo-
nia, septicaemia, meningitis, arthritis and spondylodiscitis
[5, 9–13]. It has also caused a large outbreak of post-
streptococcal glomerulonephritis in Brazil [14].
Necrotizing myositis is a very rare and potentially
lethal infection, constituting the most severe form of
necrotizing soft tissue infections (NSTI). Monomicrobial
NSTI is most often caused by Streptococcus pyogenes
(S. pyogenes), and frequently associated with septic
shock and high mortality rates [15–17]. NSTI caused
by S. zooepidemicus was recently documented in a
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dog shortly after subcutaneous vaccination [18], but
to our knowledge, human NSTI caused by S. zooepi-
demicus has not been reported previously.
Here we present a case of necrotizing myositis caused
by S. zooepidemicus in a farmer who was in close contact
with his two Shetland ponies prior to the infection.
Case presentation
A 73 –year-old male patient was transmitted with air
ambulance from a local hospital to Haukeland University
Hospital (HUH) in western Norway with septic shock
and clinical suspicion of NSTI in his left thigh.
His previous medical history included paroxysmal
atrial fibrillation, treated with flecainide, and psoriatic
arthritis. He was a farmer, with two Shetland ponies in
his stable. A few days prior to hospitalization, he had ac-
quired minor abrasions and blisters on his fingers and
subsequently been in direct contact with the ponies
upon feeding them.
In the afternoon on day 1, he was admitted to the local
hospital with acute pain in his left groin. He rapidly de-
veloped symptoms and signs of septic shock. Blood cul-
tures were drawn, and empiric antibiotic therapy with
penicillin G, clindamycin and gentamicin was initiated.
Computed tomography imaging of the pelvis and left
thigh showed possible necrotizing myositis or pyomyosi-
tis and he was thereupon rapidly transferred to a tertiary
care facility.
Upon admission at HUH day 2 the patient was intu-
bated and maintained an adequate blood pressure of
139/61 mmHg on a low-dose noradrenaline-infusion
(0.03 μg/kg/min). His temperature was 38.7 ° C and the
pulse rate was 108 per minute. A relatively sharply de-
marcated erythema in the left thigh was observed, but
neither bulla, ecchymosis or skin necrosis was present.
Blood cultures and initial blood chemistry analyses were
obtained. Further diagnostic and therapeutic strategies
were discussed in a multidisciplinary team consisting of
an orthopaedic and plastic surgeon, infectious disease
consultant and anaesthesiologist. A preoperative mag-
netic resonance tomography was rapidly performed,
revealing probable necrotizing fasciitis and myositis pri-
marily involving the adductor muscles and musculus
pectineus in the left thigh. The patient was then trans-
mitted to the operation theatre with a rapidly spreading
erythema and a fulminant septic shock, now requiring
high-dose noradrenaline infusion (0.3 μg/kg/min). Initial
blood chemistry results were as follows, with normal
range values in parentheses:
C-reactive protein 129 mg/l (<5 mg/l); leucocytes
1.5 × 109/l (3.5 × 109/l to 11.0 × 109/l); neutrophils
1.2 × 109/l (1.7 × 109/l to 8.2 × 109/l); haemoglobin
12.4 g/dl (13.4 to 17.0 g/dl); thrombocytes 85 × 109/l
(145 × 109/l to 348 × 109/l); creatinine 63 μmol/l
(60 μmol/l to 105 μmol/l); myoglobin 10,323 μmol/l
(<70 μmol/l), creatine kinase 9550 U/l (40 U/l to 80 U/l);
bilirubin 20 μmol/l (<19 μmol/l); activated partial
thromboplastin time 47 s (30 to 44 s); International
Normalized Ratio 1.3 (<1.1), lactate 4.8 mmol/l
(0.9 mmol/l to 1.7 mmol/l), procalcitonin 23.2 μg/l
(<0.1 μg/l).
At the first surgical exploration extensive muscle ne-
crosis was found, requiring excision of m. adductor
longus, along with the anterior part of m. adductor mag-
nus. Profound subcutaneous exudation (“dishwater
fluid”), but not frank pus, was also observed, compatible
with the diagnosis necrotizing myositis. Perioperative tis-
sue and fluid samples (n = 8) were obtained for micro-
biological and histopathological analyses, and a rapid
microscopic evaluation of a Gram stained smear from
the site of infection revealed Gram positive diplo- and
streptococci. The patient was transmitted to the inten-
sive care unit, with a tentative diagnosis of streptococcal
necrotizing myositis.
On day 3 cultures from blood, tissue and fluid grew
beta-haemolytic colonies on blood agar. Species identifica-
tion of the bacterial isolate as Streptococcus equi was per-
formed using matrix-assisted laser desorption ionization-
time of flight mass spectrometry (MALDI-ToF MS), using
Microflex™ with the MALDI Biotyper database (Bruker
Daltonik, Bremen, Germany) and subsequently group C
carbohydrate specificity was determined using a slide ag-
glutination test (Oxoid, Cambridge, United Kingdom).
The group C streptococcus was fully susceptible to all
tested antibiotics, with the following MIC-values: penicil-
lin G 0.016 mg/l, ceftriaxone 0.064 mg/l and clindamycin
0.25 mg/l. In order to obtain a correct subspecies identifi-
cation, the streptococcal isolate was sent to the national
reference laboratory at the Norwegian Veterinary Institute
in Oslo for further analyses.
The patient still required treatment with vasopressors
and mechanical ventilation, and continuous venovenous
hemofiltration was started due to an elevated level of
creatinine, oliguria and hyperkalaemia. Gentamicin was
discontinued, and therapy with penicillin G and clinda-
mycin was sustained. A second surgical revision was
performed, revealing progressive necrosis of the subcuta-
neous tissue and muscle of the left thigh that was treated
with a resection of almost the entire m. adductor mag-
nus and brevis, m. pectineus and m. gracilis.
The further clinical course was severe and complicated,
characterized by a need for repeated surgical excision of
necrotic tissue, hyperbaric oxygen (HBO) therapy and sus-
tained intensive care treatment of gradually resolving
organ dysfunctions and a nosocomial soft tissue super-
infection probably caused by Pseudomonas aeruginosa,
which grew from a wound specimen upon clinical deteri-
oration on treatment with penicillin G and clindamycin.
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Table 1 highlights important aspects of the clinical
course and summarizes the major microbiological find-
ings, and Fig. 1 shows the muscular necrosis, infiltration
of granulocytes and streptococci found upon histopatho-
logical analyses.
On day 11, the tracheostomy was removed. The pa-
tient was then transferred from the ICU to the infectious
disease ward at HUH and further on to the local hospital
at day 20. He was treated with penicillin and ciprofloxa-
cin until day 30, and was discharged without any signs
of systemic organ dysfunction.
Thereafter, he received physiotherapy on an outpatient
basis for a short period and quickly regained adequate
muscular function. Twelve months after discharge from
hospital he was feeling well, worked full-time and went
hiking in the local mountains on a regular basis.
Molecular analyses
The strain was identified as S. zooepidemicus according
to standard microbiological procedures at the Norwegian
Veterinary Institute [19]. In order to further identify the
strain on a molecular level we performed multilocus se-
quence typing (MLST), as previously described, with pri-
mer pairs targeting seven housekeeping genes [20]. The
sequence analyses showed that this particular strain
belonged to a new sequence type of S. zooepidemicus,
ST 364, closely related to sequence types previously re-
covered from horses and cattle (http://pubmlst.org/
szooepidemicus).
In order to explore potential virulence determinants
of ST 364, a proteomic analysis based on liquid chro-
matography-tandem mass spectrometry (LC-MS/MS) was
performed (Additional files 1 and 2). The analysis was pri-
marily based on a selection of putative virulence factors
identified in the only published S. zooepidemicus genome
associated with human infection [21], with a particular
focus on a search for homologues of selected well-known
virulence factors in S. pyogenes.
The proteomic analysis identified altogether 18 proteins
linked to S. zooepidemicus virulence (Table 2). For all of
these proteins we had derived their relative amounts by
employing the proteomic software MaxQuant, which al-
lows for proteins label-free quantification (LFQ) [22]. As a
reference protein served elongation factor TU, which is
one of the most abundant proteins in most bacterial cells
[23]. A number of virulence factors were detected at
relatively high levels in ST 364 under in vitro culturing
condition. These were cell-surface M-like protein SzM,
streptodornase SdzB, serine protease ScpC/CepA, and
several proteins involved in streptolysin S biosynthesis
(SagCDG). In addition, the analysis identified three other
proteins engaged in streptolysin S biosynthesis (SagBHI), a
putative peptidoglycan hydrolase (GbpB/SagA/PcsB), sev-
eral surface-anchored proteins (MlpZ, Fbp, SpaZ and Szp)
and enzymes that assist in breaking down the host con-
nective tissue (HylZ) and activate plasminogen (Skc_1,
Skc_2).
Discussion
This first report of zoonotic necrotizing myositis caused
by S. zooepidemicus illustrates the crucial role of a multi-
disciplinary approach at admission, rapid clinical identi-
fication, early and repeated surgery, adequate supportive
measures and appropriate antibiotics in the treatment of
NSTI. The findings from a previous study on 89 cases of
NSTI showed that time to surgery is an important prog-
nostic factor [24], and it is likely that early surgery and
meticulous surgical follow-up was a prerequisite for
therapeutic success in our case. The empiric antibiotic
treatment consisted of penicillin, clindamycin and genta-
micin, in accordance with the national antibiotic guide-
lines in Norway (http://sites.helsedirektoratet.no/sites/
antibiotikabruk-i-sykehus/Sider/default.aspx).
When the bacterial cause was identified and the anti-
biotic susceptibility pattern was confirmed, the patient
was further treated with a combination of penicillin and
clindamycin. Clindamycin has been shown to be super-
ior to beta-lactam-antibiotics in two observational stud-
ies on streptococcal NSTI, and furthermore, to reduce
mortality of severe GAS infections including toxic shock
and NSTI [25–28]. Hence, although ST 364 did not be-
long to S. pyogenes, the combination of penicillin and
clindamycin appeared to be the most sensible antibiotic
regimen, in line with the recommendations for treatment
of beta-haemolytic NSTI in the IDSA-guidelines [29].
The potential effect of HBO - therapy in NSTI has
mainly been evaluated in small, retrospective studies, in-
cluding patients with varying disease severity and a wide
range of different bacteriological aetiologies, and the re-
sults are diverging [30–32]. The findings from a recent
investigation, however, indicate that the most severely
affected NSTI-patients might benefit the most from
HBO-therapy [33]. Our patient had life-threatening sep-
sis with multiorgan-dysfunction and extensive muscle
necrosis, and received HBO-therapy on two consecutive
days. We believe that prompt and radical surgery along
with appropriate antibiotics were the treatment corner-
stones in this case, but it is conceivable that HBO-
therapy might have contributed to the relatively rapid
improvement of the infection.
Zoonotic transmission to man from asymptomatic
horses colonized with S. zooepidemicus in the upper air-
ways has previously been described [8]. Unfortunately,
nasopharyngeal swabs were not obtained from the
healthy ponies in the present case. The patient devel-
oped sores and abrasions on his fingers prior to the in-
fection, was in direct contact with the ponies while
feeding them, and had no direct contact with other
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animals before and around the time of infection. Hence,
a direct transmission of ST 364 from pony to human is
suspected and also supported the close genetic relation-
ship between ST 364 and other S. zooepidemicus se-
quence types from horses, namely ST 40, ST 138 and ST
214 (http://pubmlst.org/szooepidemicus).
According to a genomic study on animal isolates of
Streptococcus equi subspecies equi and zooepidemicus,
the former probably has evolved from an ancestral S.
zooepidemicus into a specialized pathogen primarily re-
sponsible for strangles in horses [34]. Furthermore, al-
though S. zooepidemicus is able to cause significant
respiratory tract infections in horse, they are occasion-
ally associated with asymptomatic nasopharyngeal car-
riage [1, 35]. Both S. equi subsp. equi and zooepidemicus
share extensive homology with S. pyogenes, and lateral
genetic exchange between these three streptococcal spe-
cies has been inferred [34]. In a genomic study on a S.
zooepidemicus strain responsible for an outbreak of
post-streptococcal glomerulonephritis, the majority of
the putative virulence determinants were S. pyogenes-ho-
mologues [21]. Moreover, like S. pyogenes, S. zooepidemi-
cus causing human infection tend be associated with a
wide range of severe clinical manifestations [5, 9–13].
Knowledge on virulence determinants of severe S.
zooepidemicus-infections is scarce, particularly in
humans. In the aforementioned genomic study by Beres
et al., approximately 100 genes homologous to putative
or proven virulence factors in other bacteria, primarily
S. pyogenes, were identified, including genes encoding
Fig. 1 Histological preparation of muscle biopsy (Hematoxylin-eosin
staining, × 40), showing infiltration of neutrophil granulocytes
(rightward arrows) and aggregates of streptococcal bacteria
(downward arrows), surrounded by necrotic muscular tissue
Table 2 Identification of Streptococcus equi subsp. zooepidemicus ST 364 putative virulence factors by proteomic analysis





Fibronectin/fibrinogen-binding protein fbp + 21.7 0.1
Beta-N-acetylglucosaminidase/ Hyaluronidase hylZ + 20.7 0.4
M-like protein mlpZ ++ 24.9 0.2
Secreted antigen GbpB/SagA/PcsB, putative peptidoglycan hydrolase Sez_0018 + 21.0 0.1
Streptolysin S biosynthesis protein SagB sagB + 20.7 0.1
Streptolysin S biosynthesis protein SagC sagC ++ 26.1 0.1
Streptolysin S biosynthesis protein SagD sagD ++ 25.4 0.1
Streptolysin S export protein SagG sagG ++ 26.8 0.1
Streptolysin S export transmembrane permease SagH sagH + 23.1 0.1
Streptolysin S export transmembrane permease SagI sagI + 22.3 0.1
Serine endopeptidase, lactocepin, interleukin-8 protease-like protein scpC/cepA ++ 25.1 0.1
Streptodornase type B sdzB ++ 26.6 0.2
Streptodornase type D sdzD ++ 24.1 0.1
Streptokinase; Skc_1 protein skc_1 ++ 24.3 0.1
Uncharacterized streptokinase-like protein; Skc_2 protein skc_2 + 23.7 0.1
Protective antigen-like protein, fibrinogen-and Ig-binding protein spaZ + 23.7 0.1
Antiphagocytic cell surface-anchored fibrinogen-and IgG Fc-binding protein SzM szm +++ 31.4 0.1
Fibrinogen-binding cell surface-anchored protein SzP szp + 22.0 0.3
Elongation factor Tuc tuf +++ 31.9 0.1
a An arbitrary scale of proteins cellular amounts based on the range of log2 LFQ intensities (between 19.6 and 34.0) within the sample: +++ highly abundant
protein (log2 LFQ intensity: 29–34), ++ protein present in moderate amounts (24–28), + low abundant protein (19–23)
b Label-free quantitative LFQ intensity of a protein is proportional to the quantity of the protein in the sample
c Reference protein with high cellular abundance
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factors involved in adhesion, immune response evasion,
host cell cytotoxicity, bacterial dissemination and mito-
genicity [21]. The highlighted proteomic data on ST
364 presented in this study, indicate a marked expres-
sion of homologues of virulent determinants (shown
in parenthesis) known to play a role in the pathogen-
esis of beta-haemolytic streptococcal NSTI, namely the
M protein (SzM), streptodornases (SdzB), interleukin
8-protease (SCpC/CepA), and proteins involved in the
streptolysin S biosynthesis (sag C/D/G) [36–39]. Notably,
we could not find evidence for superantigen activity in ST
364, in concordance with in a recent study on horses,
where only 50% of the S. zooepidemicus-isolates contained
superantigen-encoding genes [40].
Our molecular data does not allow for firm conclu-
sions on the virulence properties of ST 364, and call for
a more thorough genetic and proteomic dissection of
this particular strain. Furthermore, although our patient
did not have any obvious susceptibility for severe
streptococcal disease, the clinical outcome was probably
a result of a complex interplay between host factors and
bacterial virulence.
Taken together, we speculate that this case story
matches the available microbiological, molecular and
clinical data on S. zooepidemicus quite well:
We suspect that a S. zooepidemicus-strain, perhaps not
fit do produce clinically significant nasopharyngeal infec-
tion in the ponies, but potentially armed with virulence
properties homologous to those of S. pyogenes, was
transmitted to a human without known predisposition
to infection, causing a severe S. pyogenes-like clinical
picture.
Conclusion
This first case report on necrotizing myositis caused
by S. equi subsp. zooepidemicus illustrates the zoo-
notic potential and clinical versatility of this beta-
haemolytic streptococcus. It is also a reminder of the
fulminant course streptococcal NSTI can pursue, re-
quiring prompt recognition, extensive surgery, appro-
priate antibiotics and supportive treatment in the
intensive care unit.
The strain ST 364 belonged to a new sequence type
closely related to S. zooepidemicus-strains previously
identified in horses, and expressed S. pyogenes-like puta-
tive virulence determinants.
Key points
 S. zooepidemicus is primarily an animal pathogen,
but occasionally fit to produce severe zoonotic
infections, including the exceedingly rare
manifestation necrotizing myositis
 Necrotizing myositis requires prompt clinical
recognition along with adequate surgical, antibiotic
and supportive therapy
 The S. pyogenes-like, fulminant course of necrotizing
myositis caused by S. zooepidemicus might be
partially explained by homologous virulence
properties
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